Article Details
Retrieved on: 2024-02-06 03:50:10
Tags for this article:
Click the tags to see associated articles and topics
Summary
Immix Biopharma Inc., a clinical-stage biopharmaceutical company, is conducting a public stock offering on financial markets, filed with the U.S. SEC, to fund its clinical trials and for corporate financing.
Article found on: finance.yahoo.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here